Ovarian Cancer
Interim Phase II Results with Irofulven Announced
Published in Women's Health Weekly, April 22nd, 2000
The data were released at the 91st Annual Meeting of the American Association for Cancer Research (AACR), San Francisco, California, during April 2000. Irofulven (also known as MGI 114, hydroxymethylacyfulvene, or HMAF) is the first product candidate being developed by MGI Pharma from its family of proprietary cancer therapy compounds called acylfulvenes.
The primary objective of this trial, which is being sponsored by the U.S. National Cancer Institute (NCI) under a Clinical Trials Agreement...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Arthritis
Women More Likely To Have Severe Arthritis, Less Likely To Undergo Surgery - Aging
Tea Drinking Improves Bone Strength in Older Women - Carpal Tunnel Syndrome
Increased Incidence in Women Due to Hormonal and Musculoskeletal Factors - Disease Associations
Syphilis Appears to be a Cofactor for Women with HIV - Eating Disorders
Anorexia, Bulimia May Have Genetic Source - Eating Disorders
Binge Eating in Obese Women Associated with Emotional Functioning - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
